Haemophilia in Bulgaria - EHC

More documents

Recommendations

Info

DATA FOR BULGARIA • POPULATION – 7 500 000 • GROSS NATIONAL PRODUCT – AROUND 10 000 EUR PER CAPITA • HEALTHCARE BUDGET – 4.4% • PATIENTS WITH CONGENITAL COAGULOPATHIAS - 847 REGISTERED)
WHERE IS BULGARIA? BULGARIA IS A COUNTRY WITH LIMITED FINANCIAL RESOURCES
Page 1: HAEMOPHILIA IN BULGARIA T. LISSITCH
Page 5 and 6: CONGENITAL COAGULOPATHIAS IN BULGAR
Page 7 and 8: “GOLDEN ERA” OF THE TREATMENT O
Page 9 and 10: THIRD PERIOD (SINCE 1996) • EXPER
Page 11 and 12: GUIDELINES FOR THE TREATMENT TREATM
Page 13 and 14: THIRD PERIOD (SINCE 1996) • SCREE
Page 15 and 16: TWINNING PROGRAMME TRAINING OF SPEC
Page 17 and 18: MAIN PROBLEMS PRODUCTION OF PLASMA
Page 19 and 20: ACTIVITY OF BULGARIAN HEMOPHILIA SO
Page 21 and 22: EUROPEAN PRINCIPLES OF HAEMOPHILIA
Page 23 and 24: PATIENTS WITH CONGENITAL COAGULOPAT
Page 29 and 30: THIRD PERIOD LACKING PRODUCTS • F
Page 35 and 36: EDUCATION OF HEALTHCARE STAFF • T
Page 37 and 38: EDUCATIONAL BROCHURES • JOINT PRO
Page 39 and 40: RESEARCH • CLINICAL TRIALS HAEMOP
Page 41 and 42: RESEARCH • COMPREHENSIVE HAEMOPHI
Page 43 and 44: THE GOAL OF THE SECOND PROJECT IMPR
Page 45 and 46: SECOND PROJECT PARTICIPANTS • UMB
Page 47 and 48: PROJECTS IN COAGULATION DISORDERS S
Page 49 and 50: MAIN TASKS • STANDARDIZATION OF C
Page 51 and 52: MAIN RESULTS • REGULAR CONSULTATI
Page 53 and 54:
FOURTH PERIOD NEW ORGANIZATION OF T
Page 55 and 56:
FOURTH PERIOD OPTIMAL ORGANIZATION
Page 57 and 58:
FOURTH PERIOD NATIONAL HAEMOPHILIA
Page 59 and 60:
CONCLUSIONS BEST CLINICAL EFFICACY
show all

Haemophilia in Bulgaria - EHC

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?